4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001807359-26-000014
Director sold 4,938 shares at an average $39.74 ($196,230)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Epperly Melissa B, · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-15 | Sale : show line 1 in the form 10b5-1 | −4,338 | $39.65 | $172,002 | 10,500 | D |
| 2026-09-15 | Sale : show line 2 in the form 10b5-1 | −600 | $40.38 | $24,228 | 9,900 | D |
| Open-market sales · 4,938 sh · avg $39.74 · $196,230 | ||||||
Loading xslF345X06/wk-form4_1789684991.xml…